Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)-T Cells

Area of Science:

• Immunology
• Cellular Metabolism
• Cancer Therapy

Background:

• Chimeric antigen receptor (CAR) T-cell therapy shows high efficacy in hematological malignancies but struggles in solid tumors.
• The tumor microenvironment (TME) induces immunosuppression and metabolic stress, leading to CAR T-cell dysfunction and exhaustion.
• The metabolic state and mitochondrial function of CAR T-cells are critical for their therapeutic potential.

Purpose of the Study:

• To review the role of T-cell metabolism in CAR T-cell function.
• To explore metabolic interventions for enhancing CAR T-cell efficacy against solid tumors.
• To discuss strategies for adapting CAR T-cells to the nutrient-poor TME.

Main Methods:

• Review of current literature on CAR T-cell metabolism and TME.
• Analysis of T-cell subtype-specific metabolic pathways.
• Discussion of emerging metabolic reprogramming strategies.

Main Results:

• CAR T-cell dysfunction in solid tumors is linked to metabolic stress and exhaustion.
• T-cell subtypes utilize distinct metabolic pathways.
• Metabolic reprogramming can improve CAR T-cell anti-tumor activity and persistence.

Conclusions:

• Optimizing CAR T-cell metabolism is crucial for overcoming solid tumor challenges.
• Metabolic interventions offer a promising strategy to enhance CAR T-cell therapy for solid tumors.
• Further research into metabolic reprogramming can improve patient outcomes.